These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 34872450)
1. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
2. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
5. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476 [TBL] [Abstract][Full Text] [Related]
6. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma. He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630 [TBL] [Abstract][Full Text] [Related]
7. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
8. Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis. Lu R; Li Z; Yin S Biochem Genet; 2022 Oct; 60(5):1825-1844. PubMed ID: 35098409 [TBL] [Abstract][Full Text] [Related]
9. Zhang L; Bo H; Chen T; Li Q; Huan Y; Zhang S Future Oncol; 2020 Oct; 16(28):2209-2218. PubMed ID: 32762453 [No Abstract] [Full Text] [Related]
10. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. Guo YZ; Sun HH; Wang XT; Wang MT J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma. Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294 [TBL] [Abstract][Full Text] [Related]
12. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC). Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656 [TBL] [Abstract][Full Text] [Related]
13. Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs. Zhang B; Wang H; Guo Z; Zhang X J Cell Physiol; 2019 Aug; 234(10):18781-18791. PubMed ID: 30927266 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
15. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Chen L; Cai Z; Lyu K; Cai Z; Lei W Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma. Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583 [TBL] [Abstract][Full Text] [Related]
17. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma. Liu G; Zheng J; Zhuang L; Lv Y; Zhu G; Pi L; Wang J; Chen C; Li Z; Liu J; Chen L; Cai G; Zhang X Sci Rep; 2018 Oct; 8(1):15250. PubMed ID: 30323196 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas. Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J Cells; 2019 Apr; 8(4):. PubMed ID: 31010087 [TBL] [Abstract][Full Text] [Related]
19. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma. Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data. Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]